Issue 13 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

New players, new strategies, new resolve raise NIH budget to new level

Duke faces tightened NIH grant oversight over handling of past scientific misconduct

University of Michigan gets $150 million to recruit cancer researchers, fund research

AACR announces scientific award winners, new board of directors

James Holland, an oncology pioneer, dies at 92

In Brief

Society of Surgical Oncology gives service award to Wolmark and Fisher

NCCN honors contributors to the Improvement of global cancer care

City of Hope and Fivepoint partner to bring outpatient center to Orange County

Thomas Gallo named ACCC President 2018-2019

ONS elects board of directors

Cohen joins department of radiation oncology at Fox Chase

Funding Opportunities

DOD publishes funding opportunities for breast and prostate cancer programs

AACR, AstraZeneca form training partnership

Clinical Roundup

Sorafenib improves PFS in rare sarcomas, NIH-funded study shows

Zejula plus Keytruda shows activity in refractory ovarian cancer

Retrospective analysis identifies predictors of dose modification for niraparib

Drugs & Targets

FDA gives accelerated approval for Blincyto for ALL patients with minimal residual disease

Enfortumab vedotin gets breakthrough designation in urothelial cancer

FDA approves changes on Hologic's 3Dimensions Mammography System

FDA accepts application for Opdivo plus Yervoy for MSI-H or dMMR metastatic colorectal cancer for priority review

NCI Trials

NCI Trials for March

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login